|1.||Wellcome Trust Case Control Consortium: 1 article (01/2012)|
|2.||Sentí, Mariano: 1 article (01/2012)|
|3.||Subirana, Isaac: 1 article (01/2012)|
|4.||Samani, Nilesh J: 1 article (01/2012)|
|5.||Purcell, Shaun: 1 article (01/2012)|
|6.||Elosua, Roberto: 1 article (01/2012)|
|7.||Kathiresan, Sekar: 1 article (01/2012)|
|8.||Siscovick, David: 1 article (01/2012)|
|9.||Schwartz, Stephen M: 1 article (01/2012)|
|10.||Musameh, Muntaser D: 1 article (01/2012)|
|1.||Asthma (Bronchial Asthma)
12/01/1980 - "A double blind controlled trial of Bencard HDM (Migen) for the prophylaxis of asthma in a group of Zambian asthmatics failed to show any benefit. "
05/01/1978 - "The aim of the trial was to show the efficacy and safety of Migen as a 6-injection course, with or without a follow-up course of 6 maintenance doses, for the treatment of bronchial asthma. "
05/01/1978 - "Migen proved to be a good and and safe method of treating bronchial asthma due to house dust mite (D. "
08/01/1978 - "[Results of desensitization with Migen of patients with bronchial asthma caused by hypersensitivity to the mite Dermatophagoides pteronyssinus]."
08/04/1989 - "In a prospective study, 60 patients with allergic rhinoconjunctivitis and/or asthma due to house dust mites were chosen for hyposensitization treatment with Migen (M) or Pharmalgen (P). "
11/01/1979 - "Migen in the treatment of perennial rhinitis."
07/01/1982 - "The present study compared the influence of hyposensitization treatment with a tyrosine adsorbed house dust mite solution (Migen) and an aqueous house dust mite (HDM) solution on the immunological parameters in 41 adult asthma and rhinitis patients. "